MetaModix's Unattributed - VI Round

MetaModix raised a round of funding on July 12, 2018.

Metamodix is dedicated to reducing the human and financial costs of Type 2 Diabetes. The company is developing a drug-free, nonsurgical therapy with the goal of eliminating symptoms and reducing weigh…

Articles about MetaModix's Unattributed - VI Round: